. Author manuscript; available in PMC: 2014 Mar 4.

Published in final edited form as: Allergy Asthma Proc. 2010 Nov-Dec;31(6):499–506. doi: 10.2500/aap.2010.31.3399

Table 4.

Comparisons of the log-transformed peripheral blood mononuclear cell (PBMC) lymphoproliferative response to measles-mumps-rubella (MMR) vaccine viruses between subjects with and without asthma stratified by the family history of asthma

Presence of Family History of Asthma (n = 44)			Absence of Family History of Asthma (n = 146)
Asthmatic Patients (n = 8)	Nonasthmatic Patients (n = 36)	p-Value	Asthmatic Patients (n = 14)	Nonasthmatic Patients (n = 132)	p Value
PBMC lymphoproliferative response to measles vaccine virus (mean ± SE)
0.92 ± 0.31	1.54 ± 0.17	0.125	1.94 ± 0.35	1.94 ± 0.10	0.929
PBMC lymphoproliferative response to mumps vaccine virus (mean ± SE)
0.98 ± 0.64	2.20 ± 0.21	0.035	2.35 ± 0.39	2.29 ± 0.11	0.971
PBMC lymphoproliferative response to rubella vaccine virus (mean ± SE)
0.12 ± 0.37	0.97 ± 0.16	0.008	1.32 ± 0.19	1.26 ± 0.10	0.795

Negative value in mean indicates the value below zero because the results were log transformed; all p values were based on analysis of covariance adjusting for duration between MMR vaccination and enrollment in the study (i.e., collection of specimen).